Table 5 Overview of the outcome of our analysis of the impact of our intervention on the odds of receiving an low-value chronic ARM prescription over the compared periods. The table contains both the proportions of chronic ARM users that received a low-value chronic ARM and the subsequently calculated odds ratio
| Â | Proportion low-value 2021 (%) | Proportion low-value 2022 (%) | Odds ratio of receiving a low-value ARM between control/intervention over 2021/2022 + [95% CI] |
|---|---|---|---|
Control | 64,7% | 63,4% | 1.11 [0.84–1.47] |
Intervention | 64,9% | 66,0% |